|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
3P50CA196530-02S1
|
$715,091
|
$715,091
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
|
Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer
|
5P50CA196530-02
|
$2,161,996
|
$2,161,996
|
HERBST, ROY
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S1
|
$121,550
|
$18,233
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S2
|
$60,000
|
$9,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S3
|
$125,625
|
$18,844
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S4
|
$200,000
|
$30,000
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S5
|
$484,876
|
$72,731
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
3P30CA016359-37S6
|
$502,500
|
$75,375
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Comprehensive Cancer Center Support Grant
|
4P30CA016359-37
|
$2,600,006
|
$390,001
|
SCHULAM, PETER
|
YALE UNIVERSITY
|
|
|
Yale Cancer Center NCTN
|
5U10CA180826-03
|
$551,500
|
$27,575
|
HOCHSTER, HOWARD
|
YALE UNIVERSITY
|
|
|
Xuan Wei lung cancer study
|
ZIA CP010121-02378
|
$13,247
|
$13,247
|
Lan, Qing
|
DCEG (NCI)
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
3UM1CA173642-04S1
|
$170,764
|
$27,322
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Women's Health Initiative Cancer Survivor Cohort
|
4UM1CA173642-04
|
$2,396,733
|
$383,477
|
ANDERSON, GARNET
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
|
|
Winship Cancer Institute, National Clinical Trials Network Lead Academic Particip
|
5U10CA180864-03
|
$542,807
|
$81,421
|
RAMALINGAM, SURESH
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
3P30CA138292-08S1
|
$59,999
|
$12,000
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Winship Cancer Institute Cancer Center Support Grant
|
4P30CA138292-08
|
$2,038,828
|
$407,766
|
CURRAN, WALTER
|
EMORY UNIVERSITY
|
|
|
Web-based Smoking Cessation Program for Tribal College Students
|
4R01CA174481-04
|
$568,026
|
$568,026
|
CHOI, WON
|
UNIVERSITY OF KANSAS MEDICAL CENTER
|
|
|
Web and Mobile Smoking Cessation Interventions
|
4R01CA172205-04
|
$643,617
|
$643,617
|
DANAHER, BRIAN
|
OREGON RESEARCH INSTITUTE
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
3U10CA180833-02S1
|
$100,000
|
$10,000
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Washington University/ Siteman Cancer Center Lead Academic Site
|
5U10CA180833-03
|
$1,649,280
|
$164,928
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
|
Visual Media Influences on Adolescent Smoking Behavior
|
5R01CA077026-17
|
$546,001
|
$546,001
|
SARGENT, JAMES
|
DARTMOUTH COLLEGE
|
|
|
Vault-CCL21 Nanocapsule for Lung Cancer
|
3U44CA167593-03S1
|
$168,750
|
$168,750
|
SRIVASTAVA, INDRESH
|
PROTEIN SCIENCES CORPORATION
|
|
|
Vascular Biology Section
|
ZIA BC 011390
|
$1,126,266
|
$281,567
|
Lin, Pengnian Charles
|
CCR (NCI)
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
5U10CA180847-03
|
$9,808
|
$490
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY
|
|
|
Vanderbilt Network Lead Academic Participating Site for the NCTN
|
6U10CA180847-04
|
$410,211
|
$20,511
|
BERLIN, JORDAN
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of Quantitative 11C-Erlotinib PET for Imaging EGFR-Mutant Lung Cancer
|
5R01CA195493-02
|
$257,699
|
$257,699
|
MORRIS, EVAN
|
YALE UNIVERSITY
|
|
|
Validation of EGFR Protein Complexes as Molecular Diagnostics
|
1UH2CA202970-01
|
$390,763
|
$390,763
|
HAURA, ERIC
|
H. LEE MOFFITT CANCER CTR & RES INST
|
|
|
Validation of Biomarkers of Risk for the Early Detection of Lung Cancer
|
2U01CA152662-06
|
$715,735
|
$715,735
|
MASSION, PIERRE
|
VANDERBILT UNIVERSITY MEDICAL CENTER
|
|
|
Validation of 4-miRNA signature for early lung cancer detection
|
1R21CA205414-01
|
$218,987
|
$218,987
|
CHEN, GUOAN
|
UNIVERSITY OF MICHIGAN
|
|
|
Validation and Advanced Development of Glycan Node Analysis in Lung Cancer Research
|
5R33CA191110-02
|
$240,355
|
$240,355
|
BORGES, CHAD
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
|
|
Vaccine Immunotoxin and Radioimmunotherapy of Primary and Metastatic CNS Tumors
|
4P01CA154291-05
|
$2,641,256
|
$264,126
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
|
|
Vaccine and radiation for the therapy of human cancers
|
ZIA BC 010975
|
$393,241
|
$39,324
|
Hodge, James
|
CCR (NCI)
|
|
|
Vaccine and Drug Combination Therapy for Human Cancers
|
ZIA BC 010661
|
$393,241
|
$78,648
|
Hodge, James
|
CCR (NCI)
|
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-42S1
|
$125,000
|
$25,000
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UW Comprehensive Cancer Center Support
|
4P30CA014520-42
|
$4,288,496
|
$857,699
|
BAILEY, HOWARD
|
UNIVERSITY OF WISCONSIN-MADISON
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
5U10CA180870-03
|
$645,976
|
$96,896
|
GERBER, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT Southwestern NCI National Clinical Trials Network Lead Academic Site - U10
|
3U10CA180870-02S1
|
$50,000
|
$7,500
|
SCHILLER, JOAN
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
UT MD Anderson Cancer Center Network Lead Academic Participating Site (LAP)
|
5U10CA180858-03
|
$1,192,600
|
$89,445
|
ENG, CATHY
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
|
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
|
4R01CA166084-04
|
$318,652
|
$79,663
|
HERSHMAN, DAWN
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
|
Using social media data for e-cigarette surveillance and policy research
|
5R01CA192240-03
|
$431,320
|
$431,320
|
KIM, ANNICE
|
RESEARCH TRIANGLE INSTITUTE
|
|
|
Using SMART Design to Improve Symptom Management Strategies Among Cancer Patients
|
1R01CA193706-01A1
|
$566,558
|
$283,279
|
WYATT, GWEN
|
MICHIGAN STATE UNIVERSITY
|
|
|
Using Protein Interaction Networks and Combinatorial Screens to target KRAS driven cancer
|
5U01CA199216-02
|
$663,814
|
$663,814
|
JACKSON, PETER
|
STANFORD UNIVERSITY
|
|
|
Using FAP to Selectively Target Epithelial Cancers
|
4R01CA163930-05
|
$349,435
|
$174,718
|
BACHOVCHIN, WILLIAM
|
TUFTS UNIVERSITY BOSTON
|
|
|
Use of Genetically Engineered T cells Targeting Tumor Stroma to Treat Lung Cancer
|
4R01CA172921-04
|
$357,673
|
$357,673
|
ALBELDA, STEVEN
|
UNIVERSITY OF PENNSYLVANIA
|
|
|
Use of Beta-lapachone for Lung Cancer Chemotherapy
|
4R01CA102792-14
|
$335,140
|
$335,140
|
BOOTHMAN, DAVID
|
UT SOUTHWESTERN MEDICAL CENTER
|
|
|
USC Tobacco Center of Regulatory Science (TCORS) for Vulnerable Populations
|
3P50CA180905-04S1
|
$59,070
|
$44,893
|
SAMET, JONATHAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
2P30CA014089-41
|
$6,354,897
|
$63,549
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S1
|
$59,999
|
$600
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
USC Norris Comprehensive Cancer Center (Core) Grant
|
3P30CA014089-41S2
|
$37,500
|
$375
|
GRUBER, STEPHEN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
|
UPRCCC/MDACC: Partnership for Excellence in Cancer Research (1 of 2)
|
3U54CA096300-14S1
|
$72,364
|
$25,327
|
LOPEZ-BERESTEIN, GABRIEL
|
UNIVERSITY OF TX MD ANDERSON CAN CTR
|
|
Total relevant funding to Lung for this search: $283,755,731
|
